Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DEAD-box helicase 3 pseudogene 2 (DDX3P2) is a pseudogene similar in sequence to functional DEAD-box helicase genes but lacks protein-coding capacity. DEAD-box helicase family genes, such as DDX3X and DDX3Y, are involved in ATP-dependent RNA helicase activity and play roles in RNA metabolism, immune response, and several diseases, including cancers[2][3][1]. However, DDX3P2 itself is a non-functional locus thought to be derived from the DDX3Y or DDX3X genes and does not encode an active enzyme or therapeutic target[2][3]. Context and Clarification: - Pseudogenes such as DDX3P2 generally do not produce functional proteins and are not considered direct therapeutic targets or true receptors, enzymes, transporters, or transcription factors[2][3]. - Functional relevance, disease connection, and druggability apply instead to the canonical protein-coding DDX3Y and DDX3X genes, not to DDX3P2. Drugs, disease associations, and mechanisms of action referenced in the context of DEAD-box helicases or DDX3 should not be mapped to DDX3P2[1][2][3]. If you seek data on functional DEAD-box helicase 3 targets, focus on DDX3Y or DDX3X, not DDX3P2.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DEAD-box helicase 3 pseudogene 2 (DDX3P2).